Cipla Ltd. — Regulatory Filings 2025

Aug 1, 2025

==> picture [84 x 30] intentionally omitted <==

1[st] August 2025

(1) BSE Limited (2) National Stock Exchange of India Limited Listing Department, Listing Department Phiroze Jeejeebhoy Towers, Exchange Plaza, 5[th] floor, Dalal Street, Plot no. C/1, G Block, Mumbai 400 001 Bandra Kurla Complex, Bandra (East), Mumbai - 400 051 Scrip Code: 500087 Scrip Code: CIPLA EQ

(3) SOCIETE DE LA BOURSE DE Luxembourg Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg

Dear Sir/Madam,

Sub: Clarification on the news item dated 1[st] August 2025 titled ‘Pharma stocks slump as Trump shoots letters to 17 global drug majors seeking lower prices’ appearing in ‘ www.moneycontrol.com ’

We acknowledge the receipt of your email dated 1[st] August 2025, seeking clarification on the above referred news item. We wish to inform you that the Company has not received any such communication referred in the aforesaid news article and therefore we are unable to comment on the questions raised.

Further, the Company is not aware of any such information other than the information available in the public domain, which could explain the movement in the trading of its securities.

Please take the above information on record.

Yours faithfully,

For Cipla Limited

RAJENDR Digitally signed by RAJENDRA CHOPRA A CHOPRA Date: 2025.08.01 17:54:08 +05'30'

Rajendra Chopra Company Secretary

Cipla Ltd.

Regd. Office - Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400 013, India P +91 22 41916000 F +91 22 41916120 W www.cipla.com E-mail contactus@cipla.com Corporate Identity Numbe r L24239MH1935PLC002380